Back to Search
IRWIN GELMAN, M.D.
M.D.
Psychiatry Physician
NPI: 1154447282Individual
Specialties, Licenses & Credentials
Child & Adolescent Psychiatry Physician
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
183990(NY)045463(CT)
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
045463(CT)
Research & Publications (20)
v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex.
PMID 17626016·J Biol Chem·2007
7-preclinical
Isolation of novel substrates using a tyrosine kinase overlay/in situ assay.
PMID 12616718·Methods Mol Biol·2003
7-preclinical
The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development .
PMID 12133808·Front Biosci·2002
6-review
Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes.
PMID 11729253·J Am Soc Nephrol·2001
7-preclinical
Reovirus infection of cancer cells is not due to activated Ras pathway.
PMID 18949012·Cancer Gene Ther·2009
7-preclinical
Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.
PMID 19138410·BMC Cancer·2009
7-preclinical
Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.
PMID 18979199·Dig Dis Sci·2009
8-other
Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.
PMID 18593908·Cancer Res·2008
7-preclinical
v-Src-dependent down-regulation of the Ste20-like kinase SLK by casein kinase II.
PMID 16837460·J Biol Chem·2006
7-preclinical
SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition.
PMID 16740695·Cancer Res·2006
7-preclinical
SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis.
PMID 16638134·BMC Cancer·2006
7-preclinical
SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.
PMID 16547152·Mol Cancer Res·2006
7-preclinical
Enhanced v-Src-induced oncogenic transformation in the absence of focal adhesion kinase is mediated by phosphatidylinositol 3-kinase.
PMID 15809050·Biochem Biophys Res Commun·2005
7-preclinical
Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202.
PMID 15100361·J Am Soc Nephrol·2004
7-preclinical
Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles.
PMID 15496411·J Biol Chem·2004
7-preclinical
SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier.
PMID 12808449·Nat Med·2003
7-preclinical
Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol.
PMID 12654740·J Antimicrob Chemother·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 208 VALLEY RD
NEW CANAAN, CT 06840 - Phone
- (914) 261-2458
Quick Facts
- NPI
- 1154447282
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile